Supaveda · Ingredient Spotlight
Bala
Sida cordifolia L. — Country Mallow · Indian Ephedra
Also known as: Mahabala · Nagabala · Bariar · Khirethi · Bariara · Malva-branca · Sugarchikni · Kharenti · Petari
The Sanskrit name is not a metaphor. Bala means strength — directly, simply, without botanical qualification. Charaka, in the Charaka Samhita, placed Bala in the Agraya Prakarana: the best among its class of herbs, singled out for the Balya (strength-giving) action as no other herb could match. Classifying a medicinal plant as "the best at giving strength" is a remarkable claim — and it is one that three millennia of Ayurvedic clinical practice, a robust body of modern pharmacological research, and a compound profile involving some of the most studied performance-related molecules in natural products science have continued to support.
A small perennial herb or undershrub of the family Malvaceae, 20 cm to 1.2 m in height, widely distributed across tropical and subtropical regions of India, Brazil, Bangladesh, Sri Lanka, and sub-Saharan Africa, Sida cordifolia is recognised by its heart-shaped (cordifolia = heart-leaved) leaves with stellate hairs and yellow flowers. The roots are the primary medicinal part in Ayurveda — woody, with a slightly mucilaginous texture — used fresh, dried, and as the basis for classical oil preparations. 1 Phytochemically, the plant contains approximately 142 identified chemical constituents across the genus, with alkaloids, flavonoids, and ecdysteroids as the predominant groups. 2
Prakarana
💪 The Strength Herb — Two Compound Classes, One Name
When Charaka named this herb "Strength" and placed it as the best in the Balya (strength-giving) category, he was working from millennia of clinical observation. Modern pharmacology, arriving at the same plant from a completely different direction, has found something remarkable: Sida cordifolia contains two distinct compound classes that contemporary science associates with physical performance — albeit in ways that require careful, transparent discussion. 1
The first is the alkaloid fraction — which includes vasicine, vasicinone, vasicinol, and, in some studies (though this is genuinely contested — see below), ephedrine and pseudoephedrine. Ephedrine is the compound from which the pharmaceutical decongestant and bronchodilator pseudoephedrine is derived; it is also the sympathomimetic alkaloid that drove Ephedra sinica's use in weight-loss supplements before regulatory action. The second is the ecdysteroid fraction — 20-hydroxyecdysone and related steroidal compounds found concentrated in the seeds. 20-Hydroxyecdysone (20-HE) is the most-studied ecdysteroid in sports science, with multiple human clinical trials demonstrating effects on lean body mass, muscle protein synthesis rates, and physical performance — studied specifically as a legal, non-anabolic alternative to anabolic steroids. The herb named "Strength" in classical Ayurveda contains, in its seeds, the compound class that modern sports scientists are evaluating as a performance enhancer. Whether that is convergence of wisdom or pharmacological coincidence is for the reader to decide.
What the evidence actually shows — including the important caveats — is carefully addressed in the research section below.
⚖️ The Ephedrine Question — Honest Science Requires Acknowledging Controversy
This post is committed to accurate science, and that requires addressing one of the most significant controversies in Bala research directly: the presence or absence of ephedrine in Sida cordifolia is genuinely contested in the scientific literature, and responsible communication about this herb requires transparency. 4
What studies claiming ephedrine presence report: Several phytochemical studies have detected ephedrine and pseudoephedrine in aerial parts of S. cordifolia by GC-MS and HPLC analysis. The whole-plant total alkaloid content is reported at approximately 0.085% (seeds containing the highest concentration). Ephedrine was among the alkaloids identified. This led to S. cordifolia being marketed as "Indian ephedra" in weight-loss supplement markets, and the US FDA applying its 10 mg ephedrine alkaloid per dose / 40 mg per day limit to products containing the plant. PADMA 28 (a Tibetan formula containing S. cordifolia used for intermittent claudication and multiple sclerosis) specifically received a US patent for reducing the sympathomimetic side effects of its constituents — acknowledging ephedrine-like activity in the formulation.
What studies questioning ephedrine presence report: Multiple rigorous phytochemical analyses have failed to detect ephedrine in S. cordifolia root extracts specifically. The comprehensive review by Galal, Raman and Khan (Bentham Science) specifically examined the conflicting reports and concluded that the evidence for ephedrine in S. cordifolia is ambiguous and methodologically inconsistent across studies. S. cordifolia produces quinazoline alkaloids (vasicine family) as primary alkaloids — not phenethylamine-type alkaloids like ephedrine. The most pharmacologically abundant alkaloids clearly confirmed across multiple studies are vasicine, vasicinone, vasicinol, and β-phenethylamine — not ephedrine itself.
The adulteration dimension: A DNA barcoding study of market-collected "Bala" (S. cordifolia) samples found that 76% of samples belonged to other Sida species — primarily S. acuta (36%), S. spinosa (20%), S. alnifolia (12%), and others. Many papers studying "S. cordifolia" may therefore have been studying adulterant species, some of which do contain ephedrine. This botanical ambiguity makes the ephedrine controversy partly a quality-control and authentication problem rather than purely a phytochemical dispute. 4
The practical implication: Authenticated Sida cordifolia root — properly verified by HPTLC or DNA barcoding — appears to contain vasicine-family quinazoline alkaloids and ecdysteroids as primary active compounds, with ephedrine presence uncertain and likely lower than often reported in studies using unverified market material. This post presents the pharmacology of authenticated S. cordifolia and does not make claims about ephedrine content.
At a Glance — Key Evidence-Backed Benefits of Authenticated Bala
Traditional Ayurvedic & Classical Uses
Bala's classification in the Charaka Samhita is exceptional in scope and specificity. It is one of only a handful of herbs placed in the Agraya Prakarana — the chapter identifying the "best of their class" — explicitly named as the single best herb for Balya (strength-giving). It is simultaneously placed in: Brimhaniya Mahakashaya (tissue-building group), Prajasthapana Mahakashaya (foetal-stabilising group), Vata-Shamaka (Vata-pacifying), and classified as a Rasayana. The primary indications in Vatavyadhi (Vata disorders) and Vatarakta (Vata-blood, or gout) place it alongside Dashamoola and Ashwagandha as one of the great Vata-pacifying rejuvenatives. 3
In Pakshaghat (hemiplegia — one-sided paralysis), the Ayurvedic treatment protocol specifies Bala Taila — Bala oil — as the primary external application. This places Bala at the intersection of neurology and musculoskeletal medicine: a herb specifically identified for the deep nerve-and-muscle wasting that characterises Vata's most severe neurological disorders. Its Ojovardhaka (Ojas-increasing) property — the most fundamental quality of a Rasayana, building the "essence of all tissues" — positions Bala not merely as a symptomatic anti-inflammatory but as a deep restorative: rebuilding the Dhatu (tissues) that have been depleted by chronic illness, ageing, or constitutional weakness. 3
Ayurvedic Properties (Guna)
The sweet (Madhura) taste and sweet post-digestive effect (Madhura Vipaka) with cooling (Sheeta) potency creates the pharmacological profile of a building, nourishing, tissue-regenerating herb — not a stimulant. This is the Ayurvedic pharmacological signature of Brimhaniya (tissue-building) Rasayana herbs: sweet, unctuous, cooling, and slow-acting. The classical strength-giving (Balya) action is not the stimulant-driven "strength" of ephedrine — it is the deep, restorative strength that comes from building depleted tissues, stabilising the nervous system, and increasing Ojas over time.
Classical Conditions and Uses
- Nerve disorders (Vatavyadhi) — the primary classical indication; hemiplegia, facial paralysis, cervical spondylosis, neurosis, sciatica; Bala Taila as the specific external treatment for nerve-and-muscle wasting; nervine tonic action
- Weakness and emaciation (Kshaya) — the best strength-giving herb; rebuilds depleted tissues after chronic illness, fever, post-surgical wasting, or constitutional thinness; Brimhaniya (tissue-building Rasayana)
- Gout and Vata-Rakta (Vatarakta) — the Vata-blood disorder characterised by hot, painful, inflamed joints, particularly affecting the small joints and feet; anti-inflammatory, diuretic (uric acid clearance), and Vata-pacifying combination
- Respiratory disorders — bronchial asthma (Tamaka Shwasa), chronic cough, nasal congestion, blenorrhea; vasicine alkaloids as bronchodilatory mechanism (vasicinone → the compound from which the pharmaceutical ambroxol was derived); Kantakari-like respiratory action
- Reproductive health — aphrodisiac (Vrishya); increases semen quality; classified in Prajasthapana (foetal-stabilising) group; strengthens reproductive tissues; traditional use in oligospermia
- Urinary disorders — diuretic; used in gonorrhoea, cystitis, urinary colic; the Philippine folk use of leaves as emollient and diuretic aligns with the classical urinary application
- Heart conditions (Hridya) — cardiac tonic; the PADMA 28 formula containing Bala is used for atherosclerosis and intermittent claudication; classical Hridya (heart-strengthening) property
- Wounds and skin conditions — anti-inflammatory topical; wound healing; stomatitis; the ulceroprotective and anti-pyretic properties support the classical skin and wound applications
- Parkinson's disease (classical nerve-wasting) — Ayurvedic practitioners use Bala for neurodegenerative disorders including Parkinson's; the classical Kampavata (trembling Vata) indication; neuroprotective activity confirmed preclinically
- Postpartum recovery — in Sutika (postpartum) care as a tissue-building Rasayana; rebuilds depleted Dhatu (tissues) after childbirth; the Prajasthapana classification suggests uterine and reproductive tonic properties
Five Classical Varieties of Bala
Classical Ayurvedic texts describe five varieties of Bala, all considered to possess similar therapeutic properties. This is pharmacologically relevant because the "Bala" drug category in Ayurveda was understood as a functional class — herbs with Balya (strength-giving) properties — rather than a single species identity. The five recognised varieties are: 3
- Bala (Sida cordifolia L.) — the primary species; North Indian Bala; the subject of this post
- Mahabala (Sida rhombifolia L.) — "Great Bala"; large-rooted; similar alkaloid profile; often used interchangeably with S. cordifolia in South Indian practice
- Nagabala (Grewia hirsuta Vahl / Sida veronicaefolia) — "Elephant Bala"; considered most potent; specifically used for deep tissue Vata disorders
- Atibala (Abutilon indicum Linn.) — "Super Bala"; in the same Malvaceae family; similar mucilaginous properties; widely used as Bala substitute in South India
- Balatantra / Bala (South Indian) (Sida alnifolia var.) — South Indian Bala; regional variant with overlapping therapeutic applications
Key Active Compounds
Sida cordifolia contains approximately 142 identified chemical constituents across the Sida genus, with alkaloids, flavonoids, and ecdysteroids as the primary pharmacologically active classes. The root is the classical medicinal part in Ayurveda, while the seeds concentrate the highest alkaloid and ecdysteroid content. 2
Primary Bioactive Constituents
How Bala Works — Core Pharmacological Mechanisms
Bala's strength-giving, tissue-building, and neuroprotective profile is explained by five converging mechanisms — all acting within the Ayurvedic framework of reducing Vata aggravation, building depleted tissues, and stabilising the nervous system. 13
Bala's Core Therapeutic Mechanisms
What the Research Says
The foundational pharmacological validation of Bala's anti-inflammatory and analgesic properties was published in the Journal of Ethnopharmacology (Franzotti et al. 2000, PMID 10967481), using aqueous extract prepared from leaves collected before the flowering period — a methodologically important detail that reduces confounding from varying compound concentrations. 5
In the carrageenan-induced rat paw oedema model (standard acute inflammation assay), the aqueous extract at 400 mg/kg orally produced significant inhibition of oedema compared to vehicle control. Crucially, the extract did not block arachidonic acid-induced oedema — which means the anti-inflammatory mechanism operates upstream of arachidonic acid liberation, consistent with COX-enzyme pathway inhibition rather than phospholipase A2 blockade. In the acetic acid writhing test (visceral analgesic model), the extract at 400 mg/kg orally significantly inhibited the number of writhing responses. In the hot plate test (thermal analgesic model), the extract significantly increased the latency period (time before pain response), confirming central analgesic activity. Acute toxicity testing confirmed low toxicity at the therapeutic doses evaluated. These three pharmacological confirmations — anti-inflammatory by oedema inhibition, analgesic by writhing test, and central analgesic by hot plate — provide a comprehensive preclinical foundation for the classical Shothahara (anti-oedema) and Vedanasthapana (pain-relieving) properties described in the Charaka Samhita.
A peer-reviewed study published in the Indian Journal of Pharmaceutical Sciences (Sumanth and Mustafa 2009, PMC2865797) evaluated the antistress and adaptogenic activity of S. cordifolia root ethanol extract using two validated models in mice: cold restraint stress and forced swim endurance. 6
In the forced swim endurance model (forced swim test), mice pretreated with S. cordifolia extract showed significant improvement in swimming time — a validated measure of physical adaptogenic capacity (resistance to fatigue under stress). In the cold restraint stress model, the extract significantly reduced stress-induced elevation of total WBC count (a marker of stress-driven immune activation) and significantly reduced elevated plasma cortisol levels and elevated blood glucose — both markers of HPA axis stress dysregulation that adaptogens are known to normalise. The researchers concluded that Bala possesses antistress and adaptogenic activity and can be classified as a plant adaptogen, placing it alongside Ashwagandha, Brahmi, and other confirmed Ayurvedic adaptogens in the pharmacological literature. Mechanistically, Sitoindoside X — the root-specific acylsterylglycoside confirmed adaptogenic in earlier isolation studies — is the most likely primary contributor to this activity, through its role in normalising HPA axis cortisol output under stress.
A mechanistic study published in the Journal of Ethnopharmacology (ScienceDirect, 2023) investigated the therapeutic potential of S. cordifolia root extract in chronic constriction injury (CCI) — the standard experimental model for neuropathic pain — in rats, with the specific aim of identifying the molecular mechanism underlying the traditional Ayurvedic use of Bala for nerve pain, neuralgia, and sciatica. 7
The study demonstrated that S. cordifolia root extract significantly attenuated behavioural hypersensitivity (allodynia and hyperalgesia — the hallmark symptoms of neuropathic pain) in the CCI model. The molecular mechanism was identified as interference with KIF17-NR2B signalling — KIF17 is a kinesin motor protein that transports NR2B (the GluN2B subunit of NMDA glutamate receptors) to synapses; increased KIF17-NR2B signalling drives central sensitisation, the neurological mechanism underlying chronic neuropathic pain. By reducing KIF17-NR2B signalling, S. cordifolia reduces the synaptic density of NMDA receptors responsible for the wind-up phenomenon and central sensitisation in chronic pain. This is a pharmacologically sophisticated mechanism — the same NMDA receptor/central sensitisation pathway targeted by ketamine and gabapentinoids in pharmaceutical pain management. This molecular characterisation validates the classical Ayurvedic application of Bala root specifically for deep nerve conditions: cervical spondylosis, facial paralysis, hemiplegia, and sciatica.
A study published in Neurotoxicology (Khurana et al. 2013) specifically evaluated the neuroprotective potential of S. cordifolia extract in the rotenone-induced rat model of Parkinson's disease — the model most widely used to study dopaminergic neurodegeneration (rotenone inhibits mitochondrial complex I, reproducing the mitochondrial dysfunction seen in Parkinson's disease). 8
The study found that S. cordifolia extract ameliorated rotenone-induced oxidative stress — reducing lipid peroxidation (MDA), restoring SOD and catalase antioxidant enzyme activities, and reducing dopaminergic neurotoxicity markers — in the substantia nigra and striatum. This neuroprotective mechanism (mitochondrial protection via antioxidant enzyme restoration) is particularly relevant to Parkinson's disease pathophysiology. Additional supporting evidence from Auddy et al. (2003, J Ethnopharmacol) confirmed antioxidant activity of Bala in three separate neurodegenerative disease models. And Swathy et al. (2010, Neurochemical Research) confirmed antiperoxidative and anti-inflammatory effects against quinolinic acid-induced neurotoxicity — a model for excitotoxic neurodegeneration. Together these three neuroprotection studies validate the classical Ayurvedic description of Bala as the primary herb for Kampavata (Parkinson's-like trembling Vata conditions) and for general neuroprotective Rasayana use.
Two distinct lines of hepatoprotective evidence converge for Bala. The first is the isolation and characterisation of fumaric acid from S. cordifolia by Kurma and Mishra (1997, Indian Drugs) — the first isolation of this compound from the plant — with confirmed hepatoprotective activity. 9 Fumaric acid is pharmacologically significant: pharmaceutical fumaric acid esters are approved treatments for psoriasis (a classical skin indication for Bala) and relapsing multiple sclerosis (Tecfidera) — overlapping with both the classical dermatological and neurological Ayurvedic indications of the herb. The hepatoprotective mechanism involves Nrf2 pathway activation (the master antioxidant pathway), which reduces oxidative liver damage.
The second line is the anti-hyperlipidaemic evidence: a study by Asdaq et al. on hydroalcoholic extract of S. cordifolia leaves in high-fat diet rats found significant reduction in serum total cholesterol, triglycerides, and LDL cholesterol, with simultaneous increase in HDL cholesterol, alongside reduction in ALT and AST liver enzyme levels — the metabolic profile of a liver-protective, lipid-normalising herb. This validates the Ayurvedic classification of Bala as a Hridya (cardiac tonic) herb — the lipid and liver-protecting dimension of cardiovascular protection that classical physicians observed clinically and that modern pharmacology characterises as anti-atherogenic and hepatoprotective.
Key Evidence at a Glance
Classical Preparations of Bala
Bala has one of the largest collections of classical formulations of any Ayurvedic herb — appearing in decoctions, fermented preparations, oils, ghees, and major classical Rasayana formulas including Chyawanprash and Brahma Rasayana. The root is the primary medicinal part in Ayurveda; the seeds concentrate ecdysteroids and alkaloids at higher levels.
| Preparation | Description | Primary Applications |
|---|---|---|
| Bala Taila (Medicated Oil) | Sesame oil processed with Bala decoction and paste — the single most important and widely used classical Bala preparation; the specific treatment for hemiplegia (Pakshaghat) and nerve conditions; available as Chandanabalalakshadi Taila (compound version) | External Abhyanga (oil massage) for hemiplegia, facial paralysis, cervical spondylosis, sciatica, and neuropathic pain; postpartum massage; musculoskeletal weakness and wasting; daily Vata-pacifying Abhyanga for Vata constitution |
| Bala Kwatha (Decoction) | Root decoction: 10–12 g dried root pieces in 200 ml water, reduced to 50 ml; taken warm; the primary internal preparation for systemic Vata disorders and strength-building | Internal Vatavyadhi treatment; nerve weakness; post-illness rehabilitation; joint pain and Vatarakta; taken twice daily with ghee or warm milk for tissue-building; used as base for Niruha Basti (Vata-pacifying enema) |
| Bala Churna (Powder) | Dried root powder; taken with warm milk and honey; the most accessible preparation form | 3–6 g twice daily with warm milk for strength-building, tissue nourishment, and reproductive health; classical Rasayana use with warm ghee; combined with Ashwagandha and Shatavari for the complete Vata-pacifying nutritive Rasayana formula |
| Bala Ghrita (Medicated Ghee) | Ghee processed with Bala decoction; the deepest-penetrating preparation for nervous system and bone marrow tissue | Deep neurological Vata conditions; nerve wasting; bone depletion; Parkinson's disease management; 5–10 g daily with warm milk; the form providing maximum fat-soluble ecdysteroid and sitoindoside absorption into deep tissues |
| Classical Compound Formulas | Bala appears as an ingredient in: Chyawanprash (immunity Rasayana), Brahma Rasayana (cognitive Rasayana), Kumaryasava (fermented aloe preparation), Sarivadyasava, Baladikwath, Baladyarista, Masabaladi Kvatha Churna, Amritaprasa Ghrita, Dasanga Lepa | In Chyawanprash and Brahma Rasayana: foundational Balya Rasayana action ensuring all other formula ingredients have the tissue-building support framework; in Baladyarista: fermented preparation for post-illness and postpartum recovery; in Dasanga Lepa: topical anti-inflammatory paste |
Supaveda Products with Bala
Bala provides the foundational Balya (strength-giving) and Brimhaniya (tissue-building) Rasayana action in Supaveda's daily tonic:
Every classical Chyawanprash formulation includes Bala — and there is a reason. While Amla builds antioxidant immunity, Ashwagandha reduces cortisol and builds resilience, and Dashamoola pacifies Vata systemically, it is Bala that provides the foundation that makes these Rasayana herbs work: the tissue-building, Ojas-increasing, nervine-stabilising action that ensures the body can actually absorb, utilise, and benefit from the rejuvenative herbs around it. Charaka's Agraya Prakarana designation — the best strength-giving herb — is a classical way of saying: when you are depleted, when Vata has scattered and dried and weakened the tissues, no herb rebuilds the foundation of strength more effectively than Bala. The sitoindoside X adaptogens support HPA axis normalisation; the vasicine alkaloids maintain clear respiratory channels; the ecdysteroid-rich seeds provide the formula's muscle-supporting anabolic signalling; and together they deliver the deep, slow, nourishing strength that Supa Life is built to provide every day.
Safety & Precautions
Authenticated Sida cordifolia — properly identified by HPTLC or DNA barcoding — has a long traditional safety record across Ayurveda, Siddha, Unani, and folk medicine systems globally. Franzotti et al. (2000) confirmed low acute toxicity at pharmacologically effective doses. The primary safety concerns are those associated with possible sympathomimetic alkaloid content (which applies most to unverified commercial products that may contain adulterant species with higher ephedrine levels) and the general precautions for potent Vata-pacifying herbs.
Please Note
- Botanical authentication — critical: DNA barcoding showed 76% of market-labelled "Bala" samples belong to other Sida species (predominantly S. acuta — 36%). Ensure sourcing from suppliers with verified HPTLC fingerprint or DNA authentication. Unverified products carry unknown alkaloid profiles and uncertain ephedrine content — the safety concern varies significantly between authenticated S. cordifolia and substitute species.
- Sympathomimetic precautions (if ephedrine is present): Consumers with high blood pressure, heart disease, hyperthyroidism, narrow-angle glaucoma, anxiety disorders, or those taking MAO inhibitors should not use commercial S. cordifolia products without medical guidance — specifically because unverified products may contain ephedrine alkaloids at unknown levels. The US FDA limit of 10 mg ephedrine alkaloids per dose applies to products making claims about S. cordifolia content.
- Pregnancy: Vasicine and vasicinone alkaloids have documented uterotonic properties (the same class confirmed in Vasa/Adhatoda vasica). Bala is classified in the Prajasthapana (foetal-stabilising) group classically, but at therapeutic doses, uterine stimulation is plausible. Avoid therapeutic supplementation doses during pregnancy without professional Ayurvedic guidance. Bala Taila for external massage is generally considered safe in pregnancy at classical doses.
- Antidiabetic medications: Confirmed hypoglycaemic activity (Kanth and Diwan 1999); additionally, the adaptogenic action reduces cortisol-driven blood glucose elevation. Those on insulin or antidiabetics should monitor blood glucose when starting Bala supplementation.
- Kidney conditions: The sterculic and malvalic acids in seed oil have been under investigation regarding potential nephrotoxicity at high doses in animal models. Avoid very high doses long-term, particularly seed oil preparations, in those with renal disease.
- Children and CNS depressants: The confirmed CNS depressant activity means Bala may potentiate sedative medications (benzodiazepines, barbiturates, opioids). Use with caution alongside prescribed CNS depressants.
Key Takeaways
Named "Strength" — and it lives up to the name: Bala's Sanskrit name directly means strength; Charaka placed it in the Agraya Prakarana (best of class) as the single best Balya (strength-giving) herb in the entire Ayurvedic pharmacopoeia. Three thousand years of clinical observation, validated by modern pharmacology through anti-inflammatory, adaptogenic, neuroprotective, and tissue-building mechanisms
KIF17-NR2B neuropathic pain mechanism: the 2023 study revealing molecular interference with KIF17-NR2B signalling in the chronic constriction injury neuropathic pain model is the most mechanistically precise validation of the classical Vatavyadhi (nerve pain) application — providing the same molecular target addressed by pharmaceutical gabapentinoids and ketamine
Sitoindoside X — the Ashwagandha connection: the root-specific acylsterylglycoside confirmed adaptogenic and immunostimulatory from Bala roots is the same compound class as Ashwagandha's sitoindoside adaptogens — pharmacological convergence between the two most important Vata-pacifying Rasayana herbs in the classical system, now validated at the compound level
Adaptogenic classification validated: Sumanth and Mustafa (2009, PMC2865797) — significant reduction in plasma cortisol during stress, improved swim endurance, reduced stress WBC elevation, reduced stress blood glucose — all four primary markers of plant adaptogen activity confirmed; Bala classified as a plant adaptogen in modern pharmacological terminology
Vasicinone → Ambroxol lineage: the vasicine-family alkaloids of Bala are pharmacologically related to the alkaloids of Vasa (Adhatoda vasica); vasicinone is the precursor to bromhexine, which led to ambroxol — the most widely used mucolytic/expectorant globally. The classical asthma and respiratory application of Bala shares this mechanism
Fumaric acid — psoriasis, MS, and hepatoprotection: fumaric acid, first isolated from Bala by Kurma and Mishra (1997), is the active compound in Fumaderm (approved psoriasis treatment) and Tecfidera (approved MS treatment). Its presence in Bala provides a direct pharmacological bridge between the classical skin disease and neurological applications and modern approved pharmaceutical treatments
The ephedrine question — acknowledged transparently: the presence of ephedrine in S. cordifolia is scientifically contested; 76% of market samples are adulterant species (Sida acuta, S. spinosa, others); authenticated S. cordifolia root is characterised primarily by vasicine quinazoline alkaloids and sitoindoside adaptogens. Seek authenticated, verified material; be cautious with unverified commercial "Bala" products
Seeds = ecdysteroid concentrates: 20-hydroxyecdysone and 20-Hydroxy-(25-acetyl)-ecdysone-3-O-β-glucopyranoside confirmed in Bala seeds by LC-UV. 20-Hydroxyecdysone is the subject of multiple human clinical trials for lean body mass and muscle protein synthesis; non-androgenic anabolic signalling via ERβ and Akt/PI3K; the Brimhaniya (tissue-building) classical classification receives a modern pharmacological mechanism from seed-concentrated ecdysteroids
Authenticated Bala root: low acute toxicity confirmed (Franzotti et al.); long traditional safety record. Key precautions: authenticate species by HPTLC/DNA barcoding (76% market adulteration); cardiac and hypertension precautions apply to unverified products potentially containing ephedrine; uterotonic vasicine alkaloids — avoid high doses in pregnancy; monitor blood glucose with antidiabetics; caution with CNS depressants
References
- ScienceDirect (2025) 'A comprehensive overview of phytochemical composition and therapeutic applications of Sida cordifolia L.', doi: 10.1016/j.phytochem.2025.xxx (accessed via Scopus, PubMed, Google Scholar). [Key bioactive compounds: alkaloids (ephedrine, pseudoephedrine — contested presence, see ref 4; vasicinone, vasicinol — confirmed), flavonoids, phytosterols (β-sitosterol, stigmasterol), fatty acids (sterculic, malvalic, coronaric acids); anti-inflammatory, analgesic, antidiabetic, hepatoprotective, nephroprotective, anticancer, antioxidant; roots, seeds, and aerial parts; distribution morphological features, pharmacological activities].
- ScienceDirect Topics — Sida cordifolia overview. Also: Srinivasan et al. (2022) 'Sida cordifolia — an update on its traditional uses and pharmacological activities', Int J Pharm Res Allied Sci, 11(1):74–86. [142 chemical constituents across Sida genus; alkaloids, flavonoids, ecdysteroids as predominant groups; Sitoindoside X (roots) confirmed adaptogenic and immunostimulatory (Ghosal et al., Planta Med); 20-hydroxyecdysone and 20-Hydroxy-(25-acetyl)-ecdysone-3-O-β-glucopyranoside in seeds (Avula et al. 2008, LC-UV); fumaric acid hepatoprotective (Kurma and Mishra 1997); β-phenethylamine and hypaphorine in aerial parts by GC-MS; cryptolepine (indoloquinoline alkaloid) present; malvalic, sterculic, coronaric acids in seed oil].
- Maurya Bhavna, Mishra H.S. and Agarwal Ajay Kumar (2024) 'Validation of classical pharmacology of Sida cordifolia Linn. (Bala) through reverse pharmacology', Journal of Ayurveda and Integrated Medical Sciences, 9(2):204–212. [Agraya Prakarana classification — best Balya herb; Brimhaniya Mahakashaya; Prajasthapana Mahakashaya; Vatavyadhi, Vatarakta primary indications; Rasayana classification; five varieties documented; Madhur Rasa, Sheet Virya, Madhur Vipaka; classical properties: Balya, Kantikaraka, Grahi, Vrishya, Ojovardhaka, Stambhana, Brihmana, Shothahara, Hridya; CNS depressant, analgesic, anti-inflammatory, hypotensive, antidiabetic, Parkinson's disease; hypotensive and bradycardia from alkaloid fraction (Santos et al. 2005); anti-lipid profile (Asdaq et al.); anti-pyretic and anti-ulcerogenic (Philip et al., Fitoterapia); formulations: Bala Taila (SS.Ci.15.29), Chandanabalalakshadi Taila, Baladikwath, Baladya Ghrita, Baladyarista, Kumaryasava, Sarivadyasava, Chyavanaprasha, Brahma Rasayana, Masabaladi Kvatha Churna, Amritaprasa Ghrita, Dasanga Lepa].
- Galal A., Raman V. and Khan I.A. (2015) 'Sida cordifolia, a traditional herb in modern perspective — a review', Current Traditional Medicine, 1(1):5–17 (Bentham Science). [Comprehensive review of ephedrine controversy — conflicting reports examined; S. cordifolia produces primarily quinazoline alkaloids not phenethylamine-type alkaloids; ephedrine presence ambiguous and methodologically inconsistent]. Also: Mathewsopenaccess comprehensive review — vasicine, vasicinone, β-phenethylamine confirmed; ephedrine presence controversial/conflicting; S. acuta and S. rhombifolia frequently used as adulterants. Also: Vassou et al. (2015) — DNA barcoding of market Bala samples: 76% belonged to other Sida species: S. acuta 36%, S. spinosa 20%, S. alnifolia 12%, S. scabrida 4%, S. ravii 4%; remaining 24% from other genera entirely; HPTLC and DNA barcoding mandatory for authentication. Also: ScienceDirect Topics — US FDA 10 mg ephedrine alkaloids/dose limit; PADMA 28 US patent for reducing sympathomimetic side effects; alkaloid content whole plant 0.085% (seeds maximum); HPLC validated RP method for ephedrine/pseudoephedrine quantification in dietary supplements (Gurley et al. 1998).
- Franzotti, E.M., Santos, C.V., Rodrigues, H.M., Mourão, R.H., Andrade, M.R. and Antoniolli, A.R. (2000) 'Anti-inflammatory, analgesic activity and acute toxicity of Sida cordifolia L. (Malva-branca)', Journal of Ethnopharmacology, 72(1–2), pp.273–277. PMID: 10967481. [Aqueous extract from leaves before flowering; carrageenan paw oedema significant inhibition at 400 mg/kg orally; did NOT block arachidonic acid oedema (mechanism upstream of arachidonic acid liberation, consistent with COX inhibition); acetic acid writhing significant inhibition at 400 mg/kg; hot plate test significant latency increase (central analgesic); low acute toxicity confirmed; folk medicine use for oral mucosa inflammation, blenorrhea, asthmatic bronchitis, nasal congestion]. Also: Kanth, V.R. and Diwan, P.V. (1999) 'Analgesic, anti-inflammatory and hypoglycaemic activities of Sida cordifolia', Phytotherapy Research, 13(1):75–77.
- Sumanth, M. and Mustafa, S.S. (2009) 'Antistress, adoptogenic activity of Sida cordifolia roots in mice', Indian Journal of Pharmaceutical Sciences, 71(3):323–324. PMC2865797. [Ethanol extract of roots; cold restraint stress and swim endurance models in mice; significant improvement in swimming time; reduced stress-elevated WBC; reduced plasma cortisol; reduced blood glucose during stress; all four primary adaptogenic markers confirmed; HPA axis normalisation mechanism; Sitoindoside X (Ghosal et al., Planta Med) — acylsterylglycoside from roots — proposed as primary adaptogenic mechanism; categorised as plant adaptogen].
- ScienceDirect (2023) 'Sida cordifolia L. attenuates behavioral hypersensitivity by interfering with KIF17-NR2B signaling in rat model of neuropathic pain', Journal of Ethnopharmacology. [Chronic constriction injury (CCI) model of neuropathic pain in rats; significant attenuation of allodynia and hyperalgesia (behavioural hypersensitivity); KIF17 = kinesin motor protein transporting NR2B (GluN2B NMDA receptor subunit) to synapses; reduced KIF17-NR2B signalling → reduced synaptic NMDA receptor density → reduced central sensitisation wind-up; mechanism equivalent to NMDA receptor modulation targeted by gabapentinoids and ketamine; validates classical cervical spondylosis, facial paralysis, hemiplegia, sciatica, neuralgia indications; roots confirmed as primary medicinal part for nerve conditions].
- Khurana, N. and Gajbhiye, A. (2013) 'Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease', Neurotoxicology, 39:57–64. [Rotenone model (mitochondrial complex I inhibition); reduced lipid peroxidation (MDA); restored SOD and catalase; reduced dopaminergic neurotoxicity markers in substantia nigra and striatum; neuroprotective confirmed; validates classical Kampavata (trembling Vata/Parkinson's) application]. Also: Auddy, B. et al. (2003) 'Screening of antioxidant activity of three Indian medicinal plants, traditionally used for management of neurodegenerative diseases', J Ethnopharmacol, 84(2–3):131–138. Also: Swathy, S.S. et al. (2010) 'Antiperoxidative and anti-inflammatory effect of Sida cordifolia on quinolinic acid induced neurotoxicity', Neurochemical Research, 35:1361–1367.
- Kurma, S. and Mishra, S. (1997) 'Isolation and assessment of hepatoprotective activity of fumaric acid obtained for the first time from Sida cordifolia Linn.', Indian Drugs, 34(12):702–706. [First isolation of fumaric acid from S. cordifolia; hepatoprotective activity confirmed; Nrf2 pathway activation mechanism (consistent with pharmaceutical fumaric acid esters dimethyl fumarate/Fumaderm for psoriasis and Tecfidera for MS); validates classical hepatoprotective and dermatological applications through a directly characterised active compound]. Also: Asdaq, S.M.B. et al. — hydroalcoholic extract of S. cordifolia leaves; high-fat diet rats; significant reduction in total cholesterol, triglycerides, LDL; raised HDL; reduced ALT and AST; anti-atherogenic lipid profile validation; Hridya (cardiac tonic) classical property confirmed metabolically. Also: Dinda et al. (2015) 'The genus Sida L. — a traditional medicine: ethnopharmacological, phytochemical and pharmacological data', J Ethnopharmacol, 176:135–176.